Seroprevalence of Antibodies to SARS-CoV-2 in US Blood Donors

Ralph R. Vassallo, Marjorie D. Bravo, Larry J. Dumont, Kelsey Hazegh, Hany Kamel
doi: https://doi.org/10.1101/2020.09.17.20195131

Article usage

Article usage: September 2020 to November 2024

AbstractFullPdf
Sep 202010120195
Oct 2020178070
Nov 2020136045
Dec 202092035
Jan 202181035
Feb 202192052
Mar 202179756
Apr 2021100031
May 202184249
Jun 202185242
Jul 202142219
Aug 202147934
Sep 202139232
Oct 202131126
Nov 202135317
Dec 202129013
Jan 202234510
Feb 20223068
Mar 20222504
Apr 20222748
May 202229113
Jun 20222618
Jul 20222022
Aug 20222414
Sep 202246211
Oct 202234011
Nov 20222303
Dec 20222429
Jan 20231918
Feb 20232736
Mar 20232424
Apr 20232628
May 20231629
Jun 202317106
Jul 2023404
Aug 2023201714
Sep 202346106
Oct 20232175
Nov 20231574
Dec 20231744
Jan 202414310
Feb 20241332
Mar 20241337
Apr 20244257
May 20241698
Jun 20241334
Jul 202420814
Aug 20241629
Sep 20242325
Oct 20241267
Nov 2024905
Back to top
Posted September 18, 2020.
Download PDF
Data/Code
Email
Seroprevalence of Antibodies to SARS-CoV-2 in US Blood Donors
Ralph R. Vassallo, Marjorie D. Bravo, Larry J. Dumont, Kelsey Hazegh, Hany Kamel
medRxiv 2020.09.17.20195131; doi: https://doi.org/10.1101/2020.09.17.20195131
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area